Effectiveness and toxicity of high-dose cyclophosphamide in obese versus non-obese patients receiving allogeneic hematopoietic stem cell transplant
Conclusion
Obese patients receiving high-dose Cy and allo-HCT are at increased risk for toxicity, although there appears to be no difference in the rate of relapse or survival between obese and non-obese patients.
Source: Journal of Oncology Pharmacy Practice - Category: Cancer & Oncology Authors: Hunter, M. R., Sabo, R. T., McCarty, J. M., Newland, A. M. Tags: Original Articles Source Type: research
More News: Cancer & Oncology | Eating Disorders & Weight Management | Obesity | Stem Cell Therapy | Stem Cells | Study | Toxicology | Transplants